BIOTECH TARGET N V - 17 Jul 2023 Form 4 Insider Report for Molecular Templates, Inc.

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Issuer symbol: N/A
Transactions as of: 17 Jul 2023
Net transactions value: +$2,000,000
Form type: 4
Filing time: 19 Jul 2023, 15:14:58 UTC
Previous filing: 16 Feb 2023
Next filing: 11 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTEM	Common Stock	Purchase	$2,000,000	+4,255,319	+38%	$0.4700	15,447,322	17 Jul 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.